Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
MedMark Treatment Centers located in El Paso, TX, specialize in outpatient treatment for substance use with an emphasis on individualized care. The facility offers programs such as outpatient methadone/buprenorphine or naltrexone therapy, standard outpatient services, and incorporates scientifically supported methods including cognitive behavioral therapy, motivational incentives/contingency management, and the Matrix Model. Additionally, the center features specialized programs for adult men, women, and individuals affected by intimate partner or domestic violence, addressing a wide range of client needs. MedMark Treatment Centers provides exceptional care for adults and young adults of all genders, focusing on a compassionate and thorough approach to recovery from addiction.
MedMark Treatment Centers in Baltimore, MD, provides extensive outpatient care for individuals navigating detoxification, substance use disorders, and the complexities of co-occurring mental health conditions in adults or emotional challenges in youth. Their expertise lies in outpatient detox and medication-assisted treatment using methadone, buprenorphine, or naltrexone. They employ evidence-based strategies including 12-step facilitation, brief intervention, and cognitive behavioral therapy. Catering to specific populations such as adult men, adult women, and expectant or new mothers, as well as offering support for adults and young adults of all genders, MedMark delivers essential services to address a wide spectrum of community requirements.
MedStar Montgomery Medical Center, located in Olney, MD, provides a wide range of addiction recovery programs designed for both adults and children/adolescents facing substance use challenges and related mental health concerns. Its specialized inpatient offerings include detox services and continuous hospital care, emphasizing the 12-step model, short-term interventions, and cognitive behavioral therapy. The center designs customized programs for adult women, adolescents, and individuals with co-occurring disorders. Committed to delivering high-quality care, this facility serves both male and female patients in need of compassionate and effective rehabilitation support.
MedMark Treatment Centers located in Lufkin, TX, delivers extensive outpatient therapy for substance use disorders. This center features tailored programs designed for adult males, adult females, and women who are pregnant or recently gave birth. Emphasizing techniques such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing, it serves both adults and young adults of all genders. The facility provides outpatient options including methadone/buprenorphine and naltrexone treatment, alongside standard outpatient services, ensuring personalized care for each individual. With a dedication to high-quality, research-backed methods, MedMark Treatment Centers in Lufkin stands out as a reliable choice for effective addiction recovery.
MedMark Treatment Centers in Fresno, CA, delivers outpatient services for detoxification and addressing substance use disorders. This location provides treatment with methadone, buprenorphine, or naltrexone, employing proven therapeutic methods like cognitive behavioral therapy, motivational interviewing, and contingency management. Dedicated programs are available for adult men, adult women, and women who are pregnant or have recently given birth, accommodating a range of specific requirements. Catering to adults and young adults of all genders, MedMark Treatment Centers in Fresno, CA, emphasizes tailored care and ongoing encouragement for individuals navigating their path to recovery. Discover effective treatment and caring support at this center.
MedMark Treatment Centers in Fort Worth, TX, provides outpatient care for substance use disorders. Their services include methadone, buprenorphine, and naltrexone programs. The center excels in anger management, cognitive behavioral therapy, and motivational interviewing. They offer distinct programs for adult men, adult women, pregnant and postpartum women, and young adults of either gender. Prioritizing personalized support and proven therapeutic methods, MedMark Treatment Centers delivers thorough assistance for individuals pursuing recovery. The variety of tailored services guarantees individualized attention for every patient, positioning MedMark Treatment Centers as a leading provider of effective rehabilitation in Fort Worth.
MedMark Treatment Centers located in Baltimore, MD, specializes in outpatient detoxification and treatment for substance use disorders, addressing co-occurring mental health challenges in adults as well as emotional issues in children. The center employs various methodologies, including 12-step facilitation, cognitive behavioral therapy, and brief interventions. They offer specialized programs designed for adult men, women, and those who are pregnant or postpartum. Furthermore, they provide customized services for young adults and emphasize gender-specific treatment approaches for both males and females to ensure personalized care. Committed to delivering high-quality rehabilitation services, the center features a range of outpatient options such as methadone, buprenorphine, and naltrexone to support individuals in their recovery journey.
MedMark Treatment Centers in Perryopolis, PA, provides outpatient services for substance use disorders, specializing in medication-assisted treatment with methadone, buprenorphine, or naltrexone. They offer targeted therapies including anger management, cognitive behavioral therapy, and contingency management. Distinct programs are available for individuals with trauma histories, co-occurring mental health and substance use conditions, and pregnant or postpartum women. This facility supports adults and young adults of all genders, delivering personalized and thorough care to foster successful recovery. Their dedication to high-quality, individualized, and evidence-based addiction treatment makes them a dependable option.
MedMark Treatment Centers, located in Baltimore, MD, provides outpatient services for detox and substance abuse treatment for adults and young adults. Their services are designed for those managing co-occurring mental health conditions or emotional challenges. Employing strategies like 12-step program support, cognitive behavioral therapy, and brief counseling, the center delivers effective care adapted to each person's unique circumstances. Featuring distinct programs for men, women, and mothers who are pregnant or have recently given birth, MedMark Treatment Centers ensures complete assistance across all demographics. For those interested in outpatient treatment involving methadone, buprenorphine, or naltrexone, this facility is dedicated to offering individualized support to foster a successful path to recovery.
In Jasper, Alabama, MedPlex Inc Jasper is a dedicated facility providing expert care for adults and young adults battling substance use disorders. They offer outpatient counseling, incorporating medication-assisted treatment with methadone, buprenorphine, or naltrexone. Each person's recovery plan is customized to their specific requirements, reflecting a deep commitment to personalized support. MedPlex Inc Jasper is open to all genders, fostering a welcoming atmosphere. For those pursuing thorough and successful substance use disorder treatment, this center's dedication to high-quality services makes it an important ally in the path to wellness.
Medasic is an outpatient clinic in Columbia, South Carolina, providing regular outpatient substance use treatment with buprenorphine and naltrexone. It serves adults and seniors, with programs for pregnant and postpartum women, veterans, military families, and criminal justice clients. Medicare, Medicaid, TRICARE, and private insurance are accepted.
Outpatient medication treatment with buprenorphine and naltrexone is available at Medasic in Greer, South Carolina, which serves adults and seniors. Special programs cover veterans, active duty military, pregnant and postpartum women, and criminal justice clients, as well as people with co-occurring mental health disorders. Medicare, Medicaid, and TRICARE are accepted.
The Anderson, South Carolina location of Medasic offers regular outpatient substance use treatment with buprenorphine and naltrexone for adults and seniors. Programs serve pregnant and postpartum women, veterans, military families, and clients with co-occurring mental health disorders. Accepted payments include Medicare, Medicaid, TRICARE, private insurance, and self-pay.
MedMark Treatment Centers in Newton, AL, delivers outpatient services designed for adults and young adults struggling with substance use. This center extends specialized assistance to those affected by domestic violence, trauma, or living with HIV/AIDS. Employing therapeutic methods such as cognitive behavioral therapy, motivational interviewing, and contingency management, MedMark provides holistic support to all clients. Notably, MedMark Treatment Centers offers outpatient care utilizing methadone, buprenorphine, or naltrexone, focusing on high-quality, personalized plans to guide individuals toward lasting recovery.
Naltrexone-based outpatient treatment, including an intensive outpatient track, is offered at this Belen, New Mexico clinic. Programs serve pregnant and postpartum women, veterans, military families, criminal justice clients, and people with HIV or AIDS. Medicare, Medicaid, and state-financed insurance are accepted, and services are available in Spanish and sign language.
This Albuquerque, New Mexico clinic provides day treatment, intensive outpatient care, and buprenorphine or naltrexone treatment. Programs serve pregnant and postpartum women, veterans, military families, criminal justice clients, and people with HIV or AIDS. Medicare, Medicaid, and state-financed insurance are accepted, and services are available in Spanish and sign language.
MedMark Treatment Centers located in Waco, TX, delivers outpatient programs specifically designed for adult males, adult females, and those who have faced domestic or intimate partner violence. The center incorporates various therapeutic methods such as anger management, brief interventions, and cognitive behavioral therapy to assist individuals on their path to recovery. With dedicated programs catering to both men and women, as well as younger adults, MedMark ensures comprehensive support for those confronting addiction. Whether clients are looking for consistent outpatient services or specialized treatments like methadone/buprenorphine or naltrexone, MedMark Treatment Centers in Waco provides tailored care to facilitate their recovery process.
Residents of the Boiling Springs, South Carolina area can access outpatient buprenorphine and naltrexone treatment at Medasic, along with regular outpatient counseling. The clinic serves adults and seniors, including veterans, pregnant and postpartum women, and clients involved in the criminal justice system. Medicare, Medicaid, and TRICARE are among accepted payments.
MedMark Treatment Centers located in Columbus, GA, specializes in outpatient detox and treatment for substance use disorders for both adults and young adults. The center offers an extensive variety of services, such as brief interventions, cognitive behavioral therapy, and motivational incentives alongside contingency management. Emphasizing personalized care, this facility customizes treatment approaches to align with the specific requirements of each client. MedMark Treatment Centers accommodates clients of all genders, providing outpatient treatments with methadone, buprenorphine, or naltrexone. With a dedication to excellence in care, this center serves as a crucial support system for those in search of effective and tailored addiction recovery services.
MedMark Treatment Centers in Oxford, AL, provides outpatient care for addiction, featuring methadone, buprenorphine, and naltrexone options. The facility emphasizes motivational interviewing and counseling for substance use issues. It specifically supports pregnant and postpartum women, as well as adults and young adults of any gender. MedMark Treatment Centers aims for effective addiction recovery by offering personalized plans and proven therapeutic methods, ensuring high-quality support for individuals and their families in Oxford.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.